STABLECOIN DEVELOPMENT CORPORATION Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-10-10: Reporting owner WU ROY J; Form 4; Security Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-10-10: Reporting owner Stroman David W.; Form 4; Security Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-10-10: Reporting owner Khosrovi Behzad; Form 4; Security Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-10-10: Reporting owner PAULSON THOMAS J; Form 4; Security Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-10-10 | WU ROY J Officer (SVP Bus & Corp Development) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 319,902 owned after | $1.29 exercise price | $197,531.25 | 2012-10-12 |
| 2012-10-10 | Stroman David W. Officer (SVP, Ophthalmic Product Devt.) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 232,823 owned after | $1.29 exercise price | $197,531.25 | 2012-10-12 |
| 2012-10-10 | Khosrovi Behzad Officer (SVP Product Development) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 511,283 owned after | $1.29 exercise price | $197,531.25 | 2012-10-12 |
| 2012-10-10 | PAULSON THOMAS J Officer (CFO) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 554,809 owned after | $1.29 exercise price | $197,531.25 | 2012-10-12 |
| 2012-10-10 | Najafi Ramin Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 679,852 owned after | $1.29 exercise price | $197,531.25 | 2012-10-12 |
| 2012-09-27 | Tufts Robert R. Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,500 0 owned after | $0.56 | $186,812.50 | 2012-11-01 |
| 2012-09-26 | Najafi Ramin Director | 4/A | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 679,852 owned after | $1.22 exercise price | $186,812.50 | 2012-11-01 |
| 2012-09-26 | Khosrovi Behzad Officer (SVP Product Development) | 4/A | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 511,283 owned after | $1.22 exercise price | $186,812.50 | 2012-11-01 |
| 2012-09-26 | WU ROY J Officer (SVP Bus & Corp Development) | 4/A | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 319,902 owned after | $1.22 exercise price | $186,812.50 | 2012-11-01 |
| 2012-09-26 | Stroman David W. Officer (SVP, Ophthalmic Product Devt.) | 4/A | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 232,823 owned after | $1.22 exercise price | $186,812.50 | 2012-11-01 |
| 2012-09-26 | PAULSON THOMAS J Officer (CFO) | 4/A | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 554,809 owned after | $1.22 exercise price | $186,812.50 | 2012-11-01 |
| 2012-02-17 | WU ROY J Officer (SVP Bus & Corp Development) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,902 294,902 owned after | $1.44 exercise price | $220,500.00 | 2012-02-23 |
| 2012-02-17 | Stroman David W. Officer (SVP, Ophthalmic Product Devt.) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,823 207,823 owned after | $1.44 exercise price | $220,500.00 | 2012-02-23 |
| 2012-02-17 | Khosrovi Behzad Officer (SVP Product Development) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,083 486,283 owned after | $1.44 exercise price | $220,500.00 | 2012-02-23 |
| 2012-02-17 | PAULSON THOMAS J Officer (CFO) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,709 529,809 owned after | $1.44 exercise price | $220,500.00 | 2012-02-23 |
| 2012-02-17 | Najafi Ramin Director | 4 | Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,652 614,852 owned after | $1.44 exercise price | $220,500.00 | 2012-02-23 |
| 2012-01-03 | Wicks Tony D.S. Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,230 66,230 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | Tufts Robert R. Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,510 67,510 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | McPherson T. Alex Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +79,037 79,037 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | Maderis Gail J Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,510 67,510 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | Freiman Paul E. Director | 4 | Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,510 67,510 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | Dailley Anthony Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,230 66,230 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
| 2012-01-03 | Cashion Charles Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +68,791 68,791 owned after | $1.33 exercise price | $203,656.25 | 2012-01-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FORUM MARKETS Inc (FRMM) | United States | $0.069B | -0.13 |
| ZeroStack Corp. (ZSTK) | $0.069B | -0.04 | |
| Exodus Movement, Inc. (EXOD) | United States | $0.073B | 2.92 |
| SkyAI, Inc. (SKYA) | United States | $0.081B | |
| Empery Digital Inc. (EMPD) | United States | $0.082B | -0.36 |
| BTCS Inc. (BTCS) | United States | $0.085B | -0.45 |
| Marygold Companies, Inc. (MGLD) | United States | $0.044B | -11.63 |
| AVAX ONE TECHNOLOGY LTD. (AVX) | $0.040B | -0.36 | |
| FG Nexus Inc. (FGNX) | United States | $0.039B | -429.84 |
| Big Digital Energy, Inc. (BGDE) | $0.035B |